Cite
Experiences and Translatability of In Vitro andIn Vivo Models to Evaluate Caprate as a Permeation Enhancer.
MLA
Emeh, Prosper, et al. “Experiences and Translatability of In Vitro AndIn Vivo Models to Evaluate Caprate as a Permeation Enhancer.” Molecular Pharmaceutics, vol. 21, no. 1, Jan. 2024, pp. 313–24. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.3c00872.
APA
Emeh, P., Breitholtz, K., Berg, S., Vedin, C., Englund, M., Uggla, T., Antonsson, M., Nunes, F., Hilgendorf, C., Bergström, C. A. S., & Davies, N. (2024). Experiences and Translatability of In Vitro andIn Vivo Models to Evaluate Caprate as a Permeation Enhancer. Molecular Pharmaceutics, 21(1), 313–324. https://doi.org/10.1021/acs.molpharmaceut.3c00872
Chicago
Emeh, Prosper, Katarina Breitholtz, Staffan Berg, Charlotta Vedin, Maria Englund, Teresia Uggla, Malin Antonsson, et al. 2024. “Experiences and Translatability of In Vitro AndIn Vivo Models to Evaluate Caprate as a Permeation Enhancer.” Molecular Pharmaceutics 21 (1): 313–24. doi:10.1021/acs.molpharmaceut.3c00872.